NOVAREX Co.,Ltd.

A194700

KR7194700001

Food Processing

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
9,440 ^KRW	-1.05%		-1.05%	-22.24%

Mar. 21	NOVAREX Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	NOVAREX Co.,Ltd.(KOSDAQ:A194700) dropped from S&P Global BMI Index	CI

Novarex Co.,Ltd. has filed an IPO.

July 03, 2018 at 12:00 am EDT

Novarex Co.,Ltd. has filed an IPO. Security Name: Shares Security Type: Common Stock PriceRange: KRW 6500 to KRW 7500 Transaction Features: ESOP Related Offering

Latest news about NOVAREX Co.,Ltd.

NOVAREX Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
NOVAREX Co.,Ltd.(KOSDAQ:A194700) dropped from S&P Global BMI Index	23-09-18	CI
NOVAREX Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-14	CI
NOVAREX Co.,Ltd.(KOSDAQ:A194700) added to S&P Global BMI Index	19-06-24	CI
NOVAREX Co.,Ltd.(KOSDAQ:A194700) added to S&P Global BMI Index	19-06-24	CI
NOVAREX Co.,Ltd.(KOSDAQ:A194700) added to S&P Global BMI Index	19-06-24	CI
Novarex Co.,Ltd. has completed an IPO in the amount of KRW 18.24 billion.	18-11-08	CI
Novarex Co.,Ltd. has filed an IPO.	18-07-03	CI

NOVAREX Co.,Ltd. is a Korea-based company principally engaged in the manufacturing and distribution of health functional foods. The Company manufactures and sells nutritional supplement products containing vitamins and minerals; individual recognition products which are helpful for body fat reduction, eye health, and joint health; lactic acid bacteria containing products used for skin condition improvement. The Company also produces and sells coenzyme Q10 products, wild mango seed extract products, spirulina products, as well as others. The Company distributes its products within domestic market to overseas markets.

Sector

Food Processing

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for NOVAREX Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

9,440 KRW

Average target price

16,500 KRW

Spread / Average Target

+74.79%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
NOVAREX CO.,LTD.	-22.24%	123M
ZHEJIANG NHU COMPANY LTD.	+4.07%	7.38B
BELLRING BRANDS, INC.	-2.16%	7.1B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	-2.13%	5.88B
BYHEALTH CO., LTD	-3.82%	3.86B
THE SIMPLY GOOD FOODS COMPANY	-16.24%	3.24B
XIAMEN KINGDOMWAY GROUP COMPANY	-17.39%	1.12B
SIRIO PHARMA CO., LTD.	+5.02%	894M
USANA HEALTH SCIENCES, INC.	-17.67%	836M
JAMIESON WELLNESS INC.	-17.55%	790M

Special Foods & Wellbeing Products

NOVAREX Co.,Ltd.

Equities

A194700

KR7194700001

Food Processing

Novarex Co.,Ltd. has filed an IPO.

Latest news about NOVAREX Co.,Ltd.

Chart NOVAREX Co.,Ltd.

Company Profile

Income Statement Evolution

Ratings for NOVAREX Co.,Ltd.

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Special Foods & Wellbeing Products